Control Bionics Limited (ASX:CBL)
0.0590
-0.0030 (-4.84%)
At close: Mar 6, 2026
Control Bionics Market Cap
Control Bionics has a market cap or net worth of 24.31 million as of March 6, 2026. Its market cap has increased by 63.64% in one year.
Market Cap
24.31M
Enterprise Value
21.49M
Revenue
6.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.06
Market Cap Chart
Since December 7, 2020, Control Bionics's market cap has decreased from 98.33M to 24.31M, a decrease of -75.28%. That is a compound annual growth rate of -23.39%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CurveBeam AI | 31.53M |
| Atomo Diagnostics | 31.60M |
| ImpediMed | 32.62M |
| CONNEQT Health | 17.76M |
| Memphasys | 17.08M |
| OncoSil Medical | 14.76M |
| CleanSpace Holdings | 41.80M |
| Nova Eye Medical | 42.72M |